Dag Aarsland, PhD
Helse Stavanger HF · King's College London; Stavager Univeristy Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dag Aarsland, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:42 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06150261 · Effects of an Omega-3 Fatty Acid-based Supplement on Healthy AgeingHelse Stavanger HF · unknown · Healthy Aging, Ageing Well · principal investigator
- N/ANCT05829382 · A Study of Biological Effects of a Polyphenol SupplementHelse Stavanger HF · completed · Healthy Aging · principal investigator
- Ph2NCT04810104 · Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist DrugKing's College London · withdrawn · Parkinson Disease, Mild Cognitive Impairment · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:42 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.